Stock listing
NASDAQ:IMMU Immunomedics Inc Stock
Follow Immunomedics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IMMU
$87.86 USD
Close on Oct 22, 2020 · No longer trades
- Lowest – highest close
- $0.84 – $87.86 USDSince Jun 24, 1985 · lowest Mar 5, 2009 · highest Oct 22, 2020
Delisted NASDAQ:IMMU no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IMMU
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Immunomedics Inc on 6ix
- Decks
- 8 decks · latest Aug 5, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2020 Earnings Presentation | Earnings | 23 slides | Aug 5, 2020 |
| Proxy Contest (February 2017) | Proxy contest | 23 slides | Feb 10, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 19 slides | Jan 30, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 29 slides | Jan 27, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 38 slides | Jan 26, 2017 |
| Investor Day (January 2017) | Investor day | 122 slides | Jan 18, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 28 slides | Jan 18, 2017 |
| Proxy Contest (December 2016) | Proxy contest | 24 slides | Dec 14, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Director · Feb 26, 2020 – Oct 23, 2020 · Past |
| Jason M. Aryeh Other companies: Lifecore Biomedical, Inc. (Director · Since at least Aug 15, 2024); Orchestra BioMed Holdings, Inc. (Director · Since at least Jan 26, 2023); Anebulo Pharmaceuticals, Inc. (Board Member · Since at least May 6, 2021); Ligand Pharmaceuticals Incorporated (Director · Since at least May 30, 2007); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 19, 2017 · Past); Novelion Therapeutics Inc (Director · Jun 4, 2012 – May 15, 2017 · Past); Myrexis Inc (Director · Oct 19, 2011 – Jun 18, 2012 · Past); Vaxart, Inc. (Director · May 18, 2007 – May 25, 2011 · Past) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| Brian A Markison Other companies: Organogenesis Holdings Inc. (Director · Oct 7, 2016 – Dec 10, 2018 · Past); Lantheus Holdings, Inc. (CEO, Director · Jun 24, 2015 – Mar 5, 2025 · Past); Alere Inc (Director · Aug 14, 2013 – Oct 3, 2017 · Past); Altimmune, Inc. (Director · Sep 22, 2011 – Dec 31, 2014 · Past); King Pharmaceuticals Inc (President and CEO, Director · Mar 20, 2006 – Feb 28, 2011 · Past) | Director · Aug 24, 2006 – Nov 20, 2017 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past) | Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past |
| Robert Iannone Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jul 9, 2026); Autolus Therapeutics plc (Chair of the Research & Development Committee · Since at least Mar 18, 2026); Jazz Pharmaceuticals plc (EVP, Global Head of R&D & CMO · Since at least May 29, 2019); Iteos Therapeutics Inc (Director · Apr 29, 2021 – Jun 11, 2024 · Past); Jounce Therapeutics Inc (Director · Jan 21, 2020 – May 3, 2023 · Past) | CHIEF MEDICAL OFFICER · Apr 12, 2018 – Mar 14, 2019 · Past |
| Scott A Canute Other companies: Oncorus Inc (Director · Dec 11, 2020 – Jun 23, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 20, 2018 – Nov 19, 2021 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past) | Director · Apr 2, 2018 – Oct 23, 2020 · Past |
| Charles Baum Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Jun 22, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2021); Poseida Therapeutics Inc (Director · May 16, 2022 – Jan 8, 2025 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past) | Director · Feb 23, 2019 – Oct 23, 2020 · Past |
| Geoffrey F Cox Other companies: Novelion Therapeutics Inc (Director · Jun 4, 2012 – Dec 22, 2016 · Past); Vaxart, Inc. (Director · May 12, 2006 – Jun 12, 2019 · Past); GTC Biotherapeutics Inc (President, CEO and Chairman, Director · Mar 10, 2006 – Nov 2, 2009 · Past) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| Kenneth J Zuerblis Other companies: Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 10, 2020 · Past); Savient Pharmaceuticals Inc (EVP, Chief Financial Officer · Sep 12, 2011 – Feb 1, 2012 · Past); XTL Biopharmaceuticals Ltd. (Director · Oct 10, 2008 – Oct 10, 2008 · Past) | Director · Feb 9, 2010 – Dec 7, 2011 · Past |
| Khalid Islam Other companies: Gain Therapeutics, Inc. (Chairman · Since at least Mar 17, 2021); Fennec Pharmaceuticals Inc. (Chairman · Since at least Sep 11, 2017); Processa Pharmaceuticals, Inc. (Director · Nov 3, 2020 – Mar 31, 2022 · Past) | Director · Mar 13, 2017 – Oct 23, 2020 · Past |
All 30 people
| Person | Seat |
|---|---|
| Robert Forrester Other companies: Verastem, Inc. (President and CEO, Director · Jan 26, 2012 – Jan 3, 2019 · Past); Myrexis Inc (Director · Nov 11, 2010 – Dec 8, 2011 · Past); EPIRUS Biopharmaceuticals Inc (EVP and COO, Director · May 14, 2007 – Dec 21, 2009 · Past) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| Behzad Aghazadeh Other companies: Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Whitehawk Therapeutics, Inc. (Director · Since at least Aug 26, 2021) | Director · Oct 23, 2020 – Oct 23, 2020 · Past |
| Bryan Ball Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Intercept Pharmaceuticals Inc (Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past) | Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past |
| Harout Semerjian Other companies: Geron Corporation (President and Chief Executive Officer · Since at least Aug 7, 2025); Crescent Biopharma, Inc. (Chief Executive Officer, Director · Aug 6, 2021 – Jan 12, 2024 · Past) | President and CEO, Director · Apr 16, 2020 – Apr 16, 2020 · Past |
| Jared Freedberg Other companies: Arvinas, Inc. (General Counsel and Corporate Secretary · Since at least Feb 18, 2026); Intercept Pharmaceuticals Inc (General Counsel · Feb 1, 2021 – Nov 8, 2023 · Past) | Gen. Counsel & Corp. Secretary · Sep 24, 2018 – Oct 23, 2020 · Past |
| Michael Garone Other companies: Adaptimmune Therapeutics PLC (Interim CFO · Oct 1, 2019 – Oct 1, 2019 · Past); Emisphere Technologies Inc (CFO · Mar 12, 2009 – Jan 14, 2016 · Past) | Chief Financial Officer · Jun 27, 2016 – Jul 3, 2017 · Past |
| Kurt J Andrews Other companies: Amicus Therapeutics Inc (SVP, Human Resources · Feb 1, 2016 – Jul 2, 2018 · Past) | Chief Human Resources Officer · Sep 24, 2018 – Oct 23, 2020 · Past |
| Lorettta M Itri Other companies: Whitehawk Therapeutics, Inc. (CHIEF MEDICAL OFFICER · Oct 21, 2021 – Mar 1, 2024 · Past) | Chief Medical Officer · Oct 23, 2020 – Oct 23, 2020 · Past |
| Marvin Jaffe Other companies: Allos Therapeutics Inc (Director · May 10, 2006 – May 10, 2006 · Past) | Director · Aug 24, 2006 – Dec 20, 2007 · Past |
| Michael F Pehl Other companies: Celgene Corporation (See remarks · Jun 15, 2016 – Jul 28, 2017 · Past) | President and CEO · Dec 7, 2017 – Sep 14, 2018 · Past |
| Morris Rosenberg Other companies: Seagen Inc (EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past) | Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past |
| Morton Coleman Other companies: AV Therapeutics (Vice President · Feb 21, 2014 – Feb 21, 2014 · Past) | Director · Aug 24, 2006 – Dec 4, 2013 · Past |
| Richard L Sherman Other companies: Tetralogic Pharmaceuticals Corp (See Remarks · Dec 11, 2013 – Jan 28, 2015 · Past) | Director · Aug 15, 2013 – Dec 1, 2015 · Past |
| Robert L. Oliver Other companies: Exelixis, Inc. (Director · Since at least May 31, 2023) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| William Fricker Other companies: NRX Pharmaceuticals, Inc. (CFO & Treasurer · May 24, 2021 – May 24, 2021 · Past) | Principal Accounting Officer · Aug 23, 2018 – Oct 23, 2020 · Past |
| David M Goldenberg | Director · Apr 4, 2006 – Feb 28, 2018 · Past |
| Gerard G Gorman | SVP, Fin. , and CFO · Jul 9, 2007 – Aug 16, 2013 · Past |
| Marcella LoCastro | Director · Mar 6, 2012 – Dec 4, 2013 · Past |
| Mary E Paetzold | Director · Aug 24, 2006 – Dec 2, 2016 · Past |
| Usama Malik | Chief Fin. & Business Officer · Apr 12, 2018 – Oct 23, 2020 · Past |
Log in to ask 6ix AI your own questions about Immunomedics Inc.